← Back to list
Retinal Telescreening for Diabetic Retinopathy
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
Retinal telescreening with digital imaging and manual grading of images may be considered medically necessary as a screening technique for the detection of diabetic retinopathy. Digital retinal imaging with image interpretation by FDA-approved artificial intelligence software, such as IDX-DR or EyeArt, may be considered medically necessary for screening for diabetic retinopathy. Retinal telescreening is considered investigational for all other indications, including the monitoring and management of disease in individuals diagnosed with diabetic retinopathy.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.
Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.
What to do
Action · 4 steps
01Check current applicability at the source link before billing.
02Billing team: Bill CPT 92227, 92228, 92229, or 92250 for retinal telescreening only when the procedure is performed as screening for the detection of diabetic retinopathy, because the source states these codes are medically necessary only when performed according to the policy section.
03Billing team: Confirm that any AI-interpreted retinal imaging uses software approved by the FDA, such as IDX-DR or EyeArt, because the source covers only that software.
04Billing team: Treat retinal telescreening for monitoring or management of diabetic retinopathy as investigational under this policy, since the source considers it investigational.
Codes mentioned
92227922289222992250E08.3551E08.3559E08.3591E08.3599E09.3551E09.3559E09.3591E09.3599E10.10E10.9E11.00E11.9E13.00E13.9E08.311E09.311E10.311E10.3599E11.311E11.3599E13.311E13.3599
Original notice
Retinal Telescreening for Diabetic Retinopathy
bcbsms.com · Always check the source before changing claims.
Related changes
See all Blue Cross & Blue Shield of Mississippi changes →Automated Insulin Delivery SystemsMediumNo effective date · Medical PolicyDPP-4 Inhibitors and CombinationsMediumEffective May 1, 2025 · Medical PolicyGLP-1 AgonistHighEffective Apr 1, 2026 · Medical PolicyAllogeneic Pancreas TransplantMediumNo effective date · Medical PolicyBrowse every Blue Cross & Blue Shield of Mississippi change in the policy list
Related policy hubs
Blue Cross & Blue Shield of Mississippi policiesOphthalmologyOptometryCode 92227Code 92228Code 92229Code 92250Code E08.3551Code E08.3559Code E08.3591Code E08.3599Code E09.3551Code E09.3559Code E09.3591Code E09.3599Code E10.10Code E10.9Code E11.00Code E11.9Code E13.00Code E13.9Code E08.311Code E09.311Code E10.311Code E10.3599Code E11.311Code E11.3599Code E13.311Code E13.3599